Breaking News Instant updates and real-time market news.

2022-11-28 16:57:59 BTC Bitcoin / + , $BTC Bitcoin / + … 16:57 11/28/22 11/28 16:57 11/28/22 16:57	Crypto lender BlockFi files for bankruptcy amid FTX 'entanglement,' NYT says Amid the troubles for Sam Bankman-Fried's, FTX, "the embattled" crypto exchange, BlockFi, a cryptocurrency lender who serviced "ordinary investors eager for a piece of the crypto mania, filed for bankruptcy on Monday," writes Lauren Hirsch, David Yaffe-Bellany and Ephrat Livni for the NY Times. According to the NY Times story, The company said in court filings it had more than 100,000 creditors, as well as $10 billion in assets and liabilities. It also said it would reduce expenses considerably, including labor costs. It employed 850 people as of last year. Reference Link BTC Bitcoin / + $BTC Bitcoin / + BITCOIN Bitcoin / + $ETH Ethereum / + $LTC Litecoin / + GBTC Bitcoin Investment Trust $8.84 / -0.19 (-2.10%) SQ Block $61.39 / -1.95 (-3.08%) NVDA Nvidia $158.28 / -4.44 (-2.73%)	04 Jan 23 Feb

2022-11-28 16:57:59

BTC

Bitcoin

/ +

, $BTC

Bitcoin

/ +

… 16:57

11/28/22

11/28

16:57

11/28/22

16:57

Crypto lender BlockFi files for bankruptcy amid FTX 'entanglement,' NYT says

Amid the troubles for Sam Bankman-Fried's, FTX, "the embattled" crypto exchange, BlockFi, a cryptocurrency lender who serviced "ordinary investors eager for a piece of the crypto mania, filed for bankruptcy on Monday," writes Lauren Hirsch, David Yaffe-Bellany and Ephrat Livni for the NY Times. According to the NY Times story, The company said in court filings it had more than 100,000 creditors, as well as $10 billion in assets and liabilities. It also said it would reduce expenses considerably, including labor costs. It employed 850 people as of last year. Reference Link

BTC

Bitcoin

/ +

$BTC

Bitcoin

/ +

BITCOIN

Bitcoin

/ +

$ETH

Ethereum

/ +

$LTC

Litecoin

/ +

GBTC

Bitcoin Investment Trust

$8.84 / -0.19 (-2.10%)

Block

$61.39 / -1.95 (-3.08%)

NVDA

Nvidia

$158.28 / -4.44 (-2.73%)

04
Jan
23
Feb

OTHER BREAKING NEWS FROM THE FLY

Recommendations	Microsoft price target raised to $280 from $265 at Oppenheimer » 06:19 02/08/23 02/08 06:19 02/08/23 06:19 MSFT Microsoft $267.58 / +10.605 (+4.13%) Oppenheimer analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options MSFT Microsoft $267.58 / +10.605 (+4.13%) 02/07/23 Microsoft unveils new AI-powered Bing search engine and Edge browser 02/07/23 KnowBe4 joins MISA, integrates with Microsoft security products 02/07/23 Enthusiast Gaming renews partnership with Xbox 02/03/23 Activision Blizzard to pay $35M in settlement with SEC over whistleblower rule MSFT Microsoft $267.58 / +10.605 (+4.13%) 06:03 Today Piper Sandler Microsoft price target raised to $290 from $247 at Piper Sandler 05:21 Today Jefferies Microsoft price target raised to $310 from $275 at Jefferies 02/07/23 Stifel Stifel says average public ad tech multiple values Criteo near $45 per share 02/07/23 Wedbush Microsoft set to unveil ChatGPT partnership as AI arms race begins, says Wedbush MSFT Microsoft $267.58 / +10.605 (+4.13%) 01/24/23 Microsoft reports Q2 adjusted EPS $2.32, consensus $2.29 01/24/23 Notable companies reporting after market close 10/25/22 Microsoft sees FX decreasing total revenue growth by 5% in FY23 10/25/22 Microsoft reports Q1 EPS $2.35, consensus $2.30 MSFT Microsoft $267.58 / +10.605 (+4.13%) 06:04 Today Google plans to roll out AI-powered search features, WSJ reports 05:35 Today Activision CEO appeals to U.K. to approve Microsoft deal, FT reports 02/07/23 Microsoft to release ChatGPT tech to help companies make bots, CNBC says 02/07/23 Microsoft announces Bing search engine powered by OpenAI, Bloomberg says MSFT Microsoft $267.58 / +10.605 (+4.13%) 02/07/23 What You Missed On Wall Street On Tuesday 02/07/23 What You Missed This Week in Video Games 02/06/23 What You Missed On Wall Street On Monday 02/06/23 What You Missed On Wall Street This Morning MSFT Microsoft $267.58 / +10.605 (+4.13%) 01/30/23 Largest borrow rate increases among liquid names 01/27/23 Largest borrow rate increases among liquid names 01/25/23 Notable open interest changes for January 25th 01/24/23 Microsoft options imply 4.4% move in share price post-earnings
Recommendations	Chipotle price target raised to $2,084 from $1,986 at Citi » 06:18 02/08/23 02/08 06:18 02/08/23 06:18 CMG Chipotle $1,720.98 / +22.435 (+1.32%) Citi analyst Jon Tower… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options CMG Chipotle $1,720.98 / +22.435 (+1.32%) 02/07/23 Chipotle CEO: Feeling very good about where we are right now 02/07/23 Chipotle sees Q1 comparable restaurant sales growth in high-single digits 02/07/23 Chipotle reports Q4 operating margin 13.6%, up from 8.1% last year 01/26/23 Chipotle launches new hiring campaign CMG Chipotle $1,720.98 / +22.435 (+1.32%) 05:27 Today Barclays Chipotle price target raised to $1,550 from $1,450 at Barclays 01/23/23 Wells Fargo Chipotle initiated with an Overweight at Wells Fargo 01/17/23 Morgan Stanley Chipotle downgraded to Equal Weight from Overweight at Morgan Stanley 01/13/23 Evercore ISI Wendy's downgraded to In Line at Evercore, prefers share gainers CMG Chipotle $1,720.98 / +22.435 (+1.32%) 02/07/23 Chipotle reports Q4 adjusted EPS $8.29, consensus $8.90 02/07/23 Notable companies reporting after market close 10/25/22 Chipotle reports Q3 adjusted EPS $9.51, consensus $9.21 10/25/22 Notable companies reporting after market close CMG Chipotle $1,720.98 / +22.435 (+1.32%) 01/12/23 Conagra doesn't see need for 'big' price hikes in 2023, WSJ says 01/11/23 Subway looks into sale that could value company at over $10B, WSJ says 12/30/22 Restaurant coalition sues to stop California fast-food wage law, WSJ says 12/01/22 Twitter offers advertisers big incentives to boost spending, WSJ reports CMG Chipotle $1,720.98 / +22.435 (+1.32%) 02/07/23 Fly Intel: After-Hours Movers 01/24/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/17/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/07/22 #SocialStocks: EU rules against Meta, despite attempts to settle CMG Chipotle $1,720.98 / +22.435 (+1.32%) 02/07/23 Chipotle options imply 5.5% move in share price post-earnings 10/25/22 Chipotle options imply 6.3% move in share price post-earnings
Recommendations	Lululemon price target raised to $400 from $393 at Oppenheimer » 06:17 02/08/23 02/08 06:17 02/08/23 06:17 LULU Lululemon $319.15 / +7.71 (+2.48%) Oppenheimer analyst Brian… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options LULU Lululemon $319.15 / +7.71 (+2.48%) 01/12/23 lululemon teams with Nedap to advance RFID technology across stores 01/09/23 Lululemon falls 14% to $282.02 after revising Q4 guidance 12/08/22 Lululemon falls 9% to $340.75 after Q3 results and guidance 12/08/22 Lululemon reports Q3 SSS up 22% or 25% on constant FX basis LULU Lululemon $319.15 / +7.71 (+2.48%) 01/24/23 Bernstein Lululemon downgraded to Underperform from Market Perform at Bernstein 01/23/23 Jefferies Jefferies store checks find 'flaws' in Lululemon merchandising 01/13/23 Citi Lululemon price target lowered to $350 from $400 at Citi 01/13/23 Barclays Lululemon price target lowered to $394 from $445 at Barclays LULU Lululemon $319.15 / +7.71 (+2.48%) 01/09/23 Lululemon narrows Q4 adjusted EPS view to $4.22-$4.27 from $4.20-$4.30 12/08/22 Lululemon sees FY22 EPS $9.87-$9.97, consensus $9.92 12/08/22 Lululemon sees Q4 EPS $4.20-$4.30, consensus $4.30 12/08/22 Lululemon reports Q3 EPS $2.00, consensus $1.97 LULU Lululemon $319.15 / +7.71 (+2.48%) 09/30/22 Peloton tells Bloomberg resolved dispute with Lululemon over athletic wear 09/29/22 Peloton suit against Lululemon thrown out by court, Bloomberg reports 09/29/22 Lululemon wins dismissal of patent suit by Peloton, Bloomberg reports 08/17/22 Lululemon D.C. workers withdraw bid for union vote, Bloomberg reports LULU Lululemon $319.15 / +7.71 (+2.48%) 01/28/23 Buy/Sell: Wall Street's top 10 stock calls this week 01/24/23 What You Missed On Wall Street On Tuesday 01/24/23 What You Missed On Wall Street This Morning 01/24/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations LULU Lululemon $319.15 / +7.71 (+2.48%) 01/24/23 Unusually active option classes on open January 24th 01/04/23 Lululemon put volume heavy and directionally bearish 12/21/22 Unusually active option classes on open December 21st 12/12/22 Unusually active option classes on open December 12th
Recommendations	Fiserv price target raised to $135 from $122 at Citi » 06:17 02/08/23 02/08 06:17 02/08/23 06:17 FISV Fiserv $115.29 / +8.86 (+8.32%) Citi analyst Ashwin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options FISV Fiserv $115.29 / +8.86 (+8.32%) 01/19/23 Desjardins selects Fiserv to enhance credit card program 12/21/22 Fiserv enters into new contract with CEO Frank Bisignano FISV Fiserv $115.29 / +8.86 (+8.32%) 05:29 Today Barclays Fiserv price target raised to $140 from $125 at Barclays 01/23/23 Barclays Fiserv price target lowered to $125 from $128 at Barclays 01/09/23 Wells Fargo Fiserv downgraded to Underweight from Equal Weight at Wells Fargo 12/12/22 Mizuho Fiserv price target lowered to $135 from $145 at Mizuho FISV Fiserv $115.29 / +8.86 (+8.32%) 02/07/23 Fiserv sees FY23 adjusted EPS $7.25-$7.40, consensus $7.29 02/07/23 Fiserv reports Q4 adjusted EPS $1.91, consensus $1.90 02/06/23 Notable companies reporting before tomorrow's open 02/06/23 Notable companies reporting before tomorrow's open FISV Fiserv $115.29 / +8.86 (+8.32%) 02/07/23 Fly Intel: Pre-market Movers 10/27/22 Fly Intel: Pre-market Movers 10/12/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/11/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations FISV Fiserv $115.29 / +8.86 (+8.32%) 02/07/23 Early notable gainers among liquid option names on February 7th 12/14/22 Early notable gainers among liquid option names on December 14th 10/10/22 Fiserv call volume above normal and directionally bullish 08/22/22 Fiserv put volume heavy and directionally bearish
Recommendations	Paycom price target raised to $400 from $360 at Oppenheimer » 06:16 02/08/23 02/08 06:16 02/08/23 06:16 PAYC Paycom $344.55 / +14.84 (+4.50%) Oppenheimer analyst Ray… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options PAYC Paycom $344.55 / +14.84 (+4.50%) 08/15/22 Paycom raises share repurchase plan to $1.1B PAYC Paycom $344.55 / +14.84 (+4.50%) 06:13 Today Piper Sandler Paycom price target raised to $417 from $395 at Piper Sandler 01/23/23 Deutsche Bank Paycom price target lowered to $400 from $425 at Deutsche Bank 01/10/23 Barclays Paycom price target lowered to $324 from $347 at Barclays 01/09/23 MoffettNathanson Paycom initiated with an Underperform at MoffettNathanson PAYC Paycom $344.55 / +14.84 (+4.50%) 02/07/23 Paycom sees FY23 revenue $1.7B-$1.702B, consensus $1.69B 02/07/23 Paycom sees Q1 revenue $443M-$445M, consensus $437.11M 02/07/23 Paycom reports Q4 adjusted EPS $1.73, consensus $1.49 02/07/23 Notable companies reporting after market close PAYC Paycom $344.55 / +14.84 (+4.50%) 02/07/23 Fly Intel: After-Hours Movers 01/14/23 Buy/Sell: Wall Street's top 10 stock calls this week 01/09/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 09/01/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/09/23 Paycom PAYC Paycom $344.55 / +14.84 (+4.50%) 10/17/22 Early notable gainers among liquid option names on October 17th
Recommendations	Paycom price target raised to $417 from $395 at Piper Sandler » 06:13 02/08/23 02/08 06:13 02/08/23 06:13 PAYC Paycom $344.55 / +14.84 (+4.50%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options PAYC Paycom $344.55 / +14.84 (+4.50%) 08/15/22 Paycom raises share repurchase plan to $1.1B PAYC Paycom $344.55 / +14.84 (+4.50%) 01/23/23 Deutsche Bank Paycom price target lowered to $400 from $425 at Deutsche Bank 01/10/23 Barclays Paycom price target lowered to $324 from $347 at Barclays 01/09/23 MoffettNathanson Paycom initiated with an Underperform at MoffettNathanson 11/02/22 Cowen Paycom price target raised to $381 from $365 at Cowen PAYC Paycom $344.55 / +14.84 (+4.50%) 02/07/23 Paycom sees FY23 revenue $1.7B-$1.702B, consensus $1.69B 02/07/23 Paycom sees Q1 revenue $443M-$445M, consensus $437.11M 02/07/23 Paycom reports Q4 adjusted EPS $1.73, consensus $1.49 02/07/23 Notable companies reporting after market close PAYC Paycom $344.55 / +14.84 (+4.50%) 02/07/23 Fly Intel: After-Hours Movers 01/14/23 Buy/Sell: Wall Street's top 10 stock calls this week 01/09/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 09/01/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/09/23 Paycom PAYC Paycom $344.55 / +14.84 (+4.50%) 10/17/22 Early notable gainers among liquid option names on October 17th
Earnings	Perion Network sees FY23 revenue $720M-$740M, consensus $730.03M » 06:13 02/08/23 02/08 06:13 02/08/23 06:13 PERI Perion Network $33.53 / -0.21 (-0.62%) Sees FY23 adjusted EBITDA… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options PERI Perion Network $33.53 / -0.21 (-0.62%) 06:09 Today Perion Network announces six-month CEO transition period PERI Perion Network $33.53 / -0.21 (-0.62%) 01/30/23 Needham Perion Network price target raised to $37 from $32 at Needham 01/20/23 Lake Street Lake Street 'comfortable' with revenue growth forecast for Perion Network 02/10/22 Oppenheimer Perion Network price target lowered to $30 from $35 at Oppenheimer PERI Perion Network $33.53 / -0.21 (-0.62%) 06:12 Today Perion Network reports Q4 adjusted EPS 90c, consensus 59c 01/04/23 Perion Network reports preliminary FY22 revenue $636M, consensus $632.26.6M 01/04/23 Perion Network reports preliminary Q4 revenue $205M, consensus $201.6M 11/09/22 Perion Network reports Q3 EPS 61c, consensus 43c PERI Perion Network $33.53 / -0.21 (-0.62%) 01/04/23 What You Missed On Wall Street On Wednesday 01/04/23 What You Missed On Wall Street This Morning 01/04/23 Fly Intel: Pre-market Movers 10/06/22 What You Missed On Wall Street On Thursday 03/12/23 35th Annual Roth Conference 08:30 Today Perion Network - PERI PERI Perion Network $33.53 / -0.21 (-0.62%) 12/09/22 Largest borrow rate increases among liquid names 12/06/22 Largest borrow rate increases among liquid names 11/25/22 Largest borrow rate increases among liquid names
Hot Stocks	The EC transfers marketing authorization for EBVALLO from Atara to Pierre Fabre » 06:12 02/08/23 02/08 06:12 02/08/23 06:12 ATRA Atara Biotherapeutics $5.45 / +0.04 (+0.74%) Pierre Fabre and Atara… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events ATRA Atara Biotherapeutics $5.45 / +0.04 (+0.74%) 12/20/22 Atara announces $31M royalty interest financing pact with HealthCare Royalty 12/19/22 Atara Biotherapeutics chair Ron Renaud to step down, Carol Gallagher to succeed 12/19/22 Atara Biotherapeutics Ebvallo approved by EC for EBV+ PTLD therapy 12/12/22 Atara presents updated clinical data from Phase 3 trial of tab-cel ATRA Atara Biotherapeutics $5.45 / +0.04 (+0.74%) 01/04/23 EF Hutton Atara Biotherapeutics initiated with a Buy at EF Hutton 07/20/22 Citi Atara Biotherapeutics downgraded to Sell from Neutral at Citi 07/13/22 Canaccord Atara Biotherapeutics price target lowered to $50 from $67 at Canaccord 07/13/22 Stifel Stifel downgrades Atara Biotherapeutics to Hold following ATA188 analysis ATRA Atara Biotherapeutics $5.45 / +0.04 (+0.74%) 11/08/22 Atara Biotherapeutics reports Q3 EPS (82c), consensus (78c) 08/08/22 Atara Biotherapeutics reports Q2 EPS 18c, consensus (93c) ATRA Atara Biotherapeutics $5.45 / +0.04 (+0.74%) 08/09/22 What You Missed On Wall Street On Tuesday 08/09/22 What You Missed On Wall Street This Morning 02/16/23 2023 Tandem Meetings of ASTCG and CIBMTR
Recommendations	Carlyle Group price target lowered to $48 from $58 at Piper Sandler » 06:12 02/08/23 02/08 06:12 02/08/23 06:12 CG Carlyle Group $36.42 / +0.135 (+0.37%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly CG Carlyle Group $36.42 / +0.135 (+0.37%) 02/07/23 Carlyle approves increase in common stock dividend to $1.40 annual rate 02/06/23 Carlyle Group names Harvey Schwartz as CEO, board member 02/02/23 Carlyle in talks with ex-Goldman exec Schwartz for CEO role, Semafor says 01/31/23 Jasper Therapeutics discloses Carlyle Group buys $4.7M in common stock CG Carlyle Group $36.42 / +0.135 (+0.37%) 01/31/23 BMO Capital Franklin Resources price target raised to $23 from $22 at BMO Capital 01/02/23 Keefe Bruyette Carlyle Group downgraded to Market Perform from Outperform at Keefe Bruyette 01/02/23 Keefe Bruyette Apollo Global downgraded to Market Perform from Outperform at Keefe Bruyette 12/22/22 Credit Suisse Carlyle's CEO search difficulty well priced in, says Credit Suisse CG Carlyle Group $36.42 / +0.135 (+0.37%) 02/07/23 Carlyle Group reports Q4 distributable EPS $1.01, consensus 96c 11/08/22 Carlyle Group reports Q3 distributable EPS $1.42, consensus $1.06 CG Carlyle Group $36.42 / +0.135 (+0.37%) 02/06/23 Carlyle expected to name ex-Goldman exec as CEO this week, Bloomberg reports 01/13/23 Mason, Pruzan have held talks with Carlyle for CEO role, FT reports 12/22/22 Carlyle Group struggles to find permanent CEO, FT reports 11/30/22 Eni in early talks to acquire Neptune Energy for $5B-$6B, Reuters reports CG Carlyle Group $36.42 / +0.135 (+0.37%) 12/22/22 What You Missed On Wall Street On Thursday 12/22/22 What You Missed On Wall Street This Morning 11/15/22 What You Missed On Wall Street On Tuesday 11/08/22 Fly Intel: Pre-market Movers
Earnings	Perion Network reports Q4 adjusted EPS 90c, consensus 59c » 06:12 02/08/23 02/08 06:12 02/08/23 06:12 PERI Perion Network $33.53 / -0.21 (-0.62%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options PERI Perion Network $33.53 / -0.21 (-0.62%) 06:09 Today Perion Network announces six-month CEO transition period PERI Perion Network $33.53 / -0.21 (-0.62%) 01/30/23 Needham Perion Network price target raised to $37 from $32 at Needham 01/20/23 Lake Street Lake Street 'comfortable' with revenue growth forecast for Perion Network 02/10/22 Oppenheimer Perion Network price target lowered to $30 from $35 at Oppenheimer PERI Perion Network $33.53 / -0.21 (-0.62%) 01/04/23 Perion Network reports preliminary FY22 revenue $636M, consensus $632.26.6M 01/04/23 Perion Network reports preliminary Q4 revenue $205M, consensus $201.6M 11/09/22 Perion Network reports Q3 EPS 61c, consensus 43c 10/06/22 Perion reports preliminary Q3 revenue $158M, consensus $155.4M PERI Perion Network $33.53 / -0.21 (-0.62%) 01/04/23 What You Missed On Wall Street On Wednesday 01/04/23 What You Missed On Wall Street This Morning 01/04/23 Fly Intel: Pre-market Movers 10/06/22 What You Missed On Wall Street On Thursday 03/12/23 35th Annual Roth Conference 08:30 Today Perion Network - PERI PERI Perion Network $33.53 / -0.21 (-0.62%) 12/09/22 Largest borrow rate increases among liquid names 12/06/22 Largest borrow rate increases among liquid names 11/25/22 Largest borrow rate increases among liquid names

Earnings	Edgewell Personal Care sees FY23 adjusted EPS $2.30-$2.50, consensus $2.42 » 06:12 02/08/23 02/08 06:12 02/08/23 06:12 EPC Edgewell Personal Care $42.14 / -0.85 (-1.98%) Raises FY23 revenue view… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events EPC Edgewell Personal Care $42.14 / -0.85 (-1.98%) 12/16/22 Edgewell Personal Care names Robert Schmidt as Chief Accounting Officer 09/15/22 Edgewell Personal Care streamlines leadership and organizational structure EPC Edgewell Personal Care $42.14 / -0.85 (-1.98%) 11/16/22 Canaccord Canaccord starts Edgewell Personal Care at Buy amid men's 'beauty boom' 11/16/22 Canaccord Edgewell Personal Care initiated with a Buy at Canaccord 11/14/22 Barclays Edgewell Personal Care price target raised to $35 from $31 at Barclays 10/25/22 Goldman Sachs Edgewell downgraded to Neutral from Conviction Buy at Goldman Sachs EPC Edgewell Personal Care $42.14 / -0.85 (-1.98%) 06:08 Today Edgewell Personal Care reports Q1 adjusted EPS 31c, consensus 21c 11/10/22 Edgewell Personal Care sees FY23 adjusted EPS $2.30-$2.50, consensus $2.56 11/10/22 Edgewell Personal Care reports Q4 adjusted EPS 79c, consensus 76c 08:00 Today Edgewell Personal Care - EPC
Recommendations	Rockwell Medical price target lowered to $7 from $8 at H.C. Wainwright » 06:11 02/08/23 02/08 06:11 02/08/23 06:11 RMTI Rockwell Medical $1.90 / -0.07 (-3.55%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings RMTI Rockwell Medical $1.90 / -0.07 (-3.55%) 02/02/23 Rockwell Medical signs product purchase agreement with dialysis provider 01/09/23 Alimera Sciences appoints Skibsted as Chief Financial Officer, SVP 12/13/22 Rockwell Medical adds hemodialysis business in Minnesota 11/09/22 Rockwell Medical reacquires distribution rights to hemodialysis concentrates RMTI Rockwell Medical $1.90 / -0.07 (-3.55%) 08/30/22 H.C. Wainwright Rockwell Medical price target raised to $8 from $3 at H.C. Wainwright RMTI Rockwell Medical $1.90 / -0.07 (-3.55%) 11/14/22 Rockwell Medical reports Q3 EPS (40c), consensus (48c)
Initiation	Nouveau Monde initiated with a Buy at H.C. Wainwright » 06:11 02/08/23 02/08 06:11 02/08/23 06:11 NMG Nouveau Monde $5.44 / -0.11 (-1.98%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals Events NMG Nouveau Monde $5.44 / -0.11 (-1.98%) 11/11/22 Nouveau Monde provides update on Panasonic partnership 10/20/22 Nouveau Monde rises 7.7% 10/20/22 Nouveau Monde, Mitsui and Panasonic enter offtake partnership 08/29/22 Nouveau Monde falls -5.6% NMG Nouveau Monde $5.44 / -0.11 (-1.98%) 10/27/22 B. Riley Nouveau Monde assumed with a Buy at B. Riley NMG Nouveau Monde $5.44 / -0.11 (-1.98%) 09/01/22 Tesla recently visited Nouveau Monde's graphite site in Quebec, Electrek says 03/12/23 35th Annual Roth Conference
Recommendations	Vertex Pharmaceuticals price target raised to $325 from $300 at H.C. Wainwright » 06:09 02/08/23 02/08 06:09 02/08/23 06:09 VRTX Vertex Pharmaceuticals $308.78 / +3.835 (+1.26%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options VRTX Vertex Pharmaceuticals $308.78 / +3.835 (+1.26%) 02/07/23 Vertex Pharmaceuticals board authorizes $3.0B buyback 01/11/23 Vertex Pharmaceuticals expands collaboration with Arbor Biotechnologies 12/12/22 FDA clears Vertex IND application for VX-522 to treat CF 12/08/22 Vertex Pharmaceuticals, Entrada Therapeutics enter EEV therapeutics pact VRTX Vertex Pharmaceuticals $308.78 / +3.835 (+1.26%) 05:40 Today Barclays Vertex Pharmaceuticals price target raised to $342 from $313 at Barclays 01/19/23 Piper Sandler Vertex Pharmaceuticals price target raised to $296 from $293 at Piper Sandler 01/18/23 Canaccord Vertex Pharmaceuticals initiated with a Hold at Canaccord 01/17/23 SVB Securities SVB Securities upgrades Vertex to Outperform, raises price target to $374 VRTX Vertex Pharmaceuticals $308.78 / +3.835 (+1.26%) 02/07/23 Vertex Pharmaceuticals guides FY23 revenue $9.55B-$9.70B, consensus $9.6B 02/07/23 Vertex Pharmaceuticals reports Q4 EPS $3.76, consensus $3.51 02/07/23 Notable companies reporting after market close 10/27/22 Vertex Pharmaceuticals raises 2022 revenue to $8.8B-$8.9B from $8.6B-$8.9B VRTX Vertex Pharmaceuticals $308.78 / +3.835 (+1.26%) 02/07/23 Vertex keeps cystic fibrosis drug out of developing countries, NY Times reports VRTX Vertex Pharmaceuticals $308.78 / +3.835 (+1.26%) 12/30/22 What You Missed On Wall Street This Morning 12/19/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 10/31/22 Biotech Alert: Searches spiking for these stocks today 10/27/22 Fly Intel: After-Hours Movers 02/24/23 Vertex Pharmaceuticals VRTX Vertex Pharmaceuticals $308.78 / +3.835 (+1.26%) 02/07/23 Vertex options imply 3.7% move in share price post-earnings 11/28/22 Early notable gainers among liquid option names on November 28th 09/16/22 Early notable gainers among liquid option names on September 16th 09/01/22 Early notable gainers among liquid option names on September 1st
Hot Stocks	Coherent transfer listing to NYSE from Nasdaq » 06:09 02/08/23 02/08 06:09 02/08/23 06:09 COHR Coherent $43.90 / +1.2 (+2.81%) Coherent announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options COHR Coherent $43.90 / +1.2 (+2.81%) 10/18/22 Coherent appoints Julie Sheridan Eng as Chief Technology Officer 10/17/22 Windstream partners with Coherent, Nokia for 400 Gig networking 09/16/22 Coherent introduces ultrahigh-resolution telemetry module 09/15/22 Coherent introduces 200G indium phosphide EMLs for datacenter transceivers COHR Coherent $43.90 / +1.2 (+2.81%) 01/23/23 Barclays Coherent price target raised to $36 from $30 at Barclays 01/17/23 Rosenblatt Coherent initiated with a Buy at Rosenblatt 01/11/23 Craig-Hallum Lumentum price target lowered to $75 from $80 at Craig-Hallum 12/20/22 JPMorgan Coherent price target lowered to $52 from $74 at JPMorgan COHR Coherent $43.90 / +1.2 (+2.81%) 11/09/22 Coherent sees FY23 revenue $5.25B-$5.55B, consensus $5.43B 11/09/22 Coherent sees Q2 adjusted EPS 88c-$1.00, consensus 94c 11/09/22 Coherent reports Q1 adjusted EPS $1.04, consensus 83c COHR Coherent $43.90 / +1.2 (+2.81%) 11/11/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/09/22 What You Missed On Wall Street On Wednesday 11/09/22 What You Missed On Wall Street This Morning 03/07/23 Craig-Hallum Hosted Company Events at OFC 2023 09:00 Today Coherent - COHR 03/08/23 Coherent 03/08/23 Coherent 03/08/23 Coherent COHR Coherent $43.90 / +1.2 (+2.81%) 09/08/22 Four new option listings and two option delistings on September 8th
Upgrade	TripAdvisor upgraded to Buy from Underperform at BofA » 06:09 02/08/23 02/08 06:09 02/08/23 06:09 TRIP TripAdvisor $24.16 / +0.46 (+1.94%) BofA analyst Nat… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options TRIP TripAdvisor $24.16 / +0.46 (+1.94%) 11/30/22 TripAdvisor says Kanika Soni to leave position as Chief Commercial Officer 11/15/22 TripAdvisor names John Boris as Chief Marketing Officer 11/08/22 TripAdvisor: 'Premature' to provide 2023 outlook 11/08/22 TripAdvisor: Travel remains 'robust' TRIP TripAdvisor $24.16 / +0.46 (+1.94%) 12/07/22 Wolfe Research TripAdvisor downgraded to Underperform from Peer Perform at Wolfe Research 11/25/22 DA Davidson TripAdvisor price target lowered to $30 from $33 at DA Davidson 11/09/22 Wells Fargo TripAdvisor price target lowered to $22 from $30 at Wells Fargo 11/09/22 Mizuho TripAdvisor price target lowered to $22 from $26 at Mizuho TRIP TripAdvisor $24.16 / +0.46 (+1.94%) 11/07/22 TripAdvisor sees Q4 revenue of low-single digit increases from 2019 levels 11/07/22 TripAdvisor reports Q3 adjusted EPS 28c, consensus 38c 11/07/22 Notable companies reporting after market close TRIP TripAdvisor $24.16 / +0.46 (+1.94%) 12/10/22 Buy/Sell: Wall Street's top 10 stock calls this week 12/07/22 What You Missed On Wall Street On Wednesday 12/07/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/08/22 What You Missed On Wall Street On Tuesday 02/15/23 TripAdvisor - TRIP TRIP TripAdvisor $24.16 / +0.46 (+1.94%) 12/07/22 TripAdvisor put volume heavy and directionally bearish 11/07/22 TripAdvisor options imply 11.1% move in share price post-earnings
Hot Stocks	Perion Network announces six-month CEO transition period » 06:09 02/08/23 02/08 06:09 02/08/23 06:09 PERI Perion Network $33.53 / -0.21 (-0.62%) Perion Network announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings On The Fly Events Options PERI Perion Network $33.53 / -0.21 (-0.62%) 01/30/23 Needham Perion Network price target raised to $37 from $32 at Needham 01/20/23 Lake Street Lake Street 'comfortable' with revenue growth forecast for Perion Network 02/10/22 Oppenheimer Perion Network price target lowered to $30 from $35 at Oppenheimer PERI Perion Network $33.53 / -0.21 (-0.62%) 01/04/23 Perion Network reports preliminary FY22 revenue $636M, consensus $632.26.6M 01/04/23 Perion Network reports preliminary Q4 revenue $205M, consensus $201.6M 11/09/22 Perion Network reports Q3 EPS 61c, consensus 43c 10/06/22 Perion reports preliminary Q3 revenue $158M, consensus $155.4M PERI Perion Network $33.53 / -0.21 (-0.62%) 01/04/23 What You Missed On Wall Street On Wednesday 01/04/23 What You Missed On Wall Street This Morning 01/04/23 Fly Intel: Pre-market Movers 10/06/22 What You Missed On Wall Street On Thursday 03/12/23 35th Annual Roth Conference 08:30 Today Perion Network - PERI PERI Perion Network $33.53 / -0.21 (-0.62%) 12/09/22 Largest borrow rate increases among liquid names 12/06/22 Largest borrow rate increases among liquid names 11/25/22 Largest borrow rate increases among liquid names
Recommendations	Target price target raised to $220 from $200 at Piper Sandler » 06:08 02/08/23 02/08 06:08 02/08/23 06:08 TGT Target $174.77 / +0.885 (+0.51%) , BBBY Bed Bath & Beyond $3.01 / -2.84 (-48.55%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options TGT BBBY TGT Target $174.77 / +0.885 (+0.51%) 01/31/23 Target says Omaha West store closed until further notice following incident 01/09/23 Mattel's Fisher-Price re-announces recall of 4.7M Rock 'n Play Sleepers 12/22/22 Target recalls roughly 204,000 children's weighted blankets after two deaths 11/25/22 Target announces Cyber Monday sales event from Nov. 27-28 BBBY Bed Bath & Beyond $3.01 / -2.84 (-48.55%) 02/07/23 Bed Bath & Beyond: Default under credit agreement waived 02/07/23 Bed Bath & Beyond has initiated incremental store closures 02/07/23 Bed Bath & Beyond completes public equity offering 02/07/23 Bed Bath & Beyond completes public equity offering, provides strategic update TGT BBBY TGT Target $174.77 / +0.885 (+0.51%) 02/07/23 Barclays Barclays sees a 'reset' in U.S. retail but 'not a recession yet' 02/07/23 Barclays Target initiated with an Equal Weight at Barclays 01/23/23 Oppenheimer Target initiated with an Outperform at Oppenheimer 01/04/23 Wells Fargo Wells Fargo downgrades Target to Equal Weight, lowers price target to $142 BBBY Bed Bath & Beyond $3.01 / -2.84 (-48.55%) 02/07/23 Odeon Capital Bed Bath & Beyond downgraded to Sell from Hold at Odeon Capital 02/07/23 Wedbush Wedbush cuts Bed Bath & Beyond target to 0c amid last effort to avoid bankruptcy 01/11/23 Wedbush Bed Bath & Beyond price target lowered to $1 from $5 at Wedbush 01/11/23 Baird Bed Bath & Beyond price target lowered to $1.00 from $2.00 at Baird TGT BBBY TGT Target $174.77 / +0.885 (+0.51%) 11/16/22 Target on track to deliver total sales of well over $100B this year, says COO 11/16/22 Target reports Q3 adjusted EPS $1.54, consensus $2.13 11/15/22 Notable companies reporting before tomorrow's open 11/15/22 Notable companies reporting before tomorrow's open BBBY Bed Bath & Beyond $3.01 / -2.84 (-48.55%) 01/10/23 Bed Bath & Beyond reports Q3 adjusted EPS ($3.65), consensus ($2.11) 01/05/23 Bed Bath & Beyond sees Q3 net sales of about $1.26B, consensus $1.4B 09/29/22 Bed Bath & Beyond reports Q2 adjusted EPS ($3.22), consensus ($1.85) 09/28/22 Notable companies reporting before tomorrow's open TGT BBBY TGT Target $174.77 / +0.885 (+0.51%) 11/14/22 Walmart taking 'aggressive' stance with suppliers, WSJ reports 10/15/22 Shortages have turned to gluts, off-price retailers could benefit, Barron's says 09/03/22 Target's problems won't last forever, time to buy stock, Barron's says BBBY Bed Bath & Beyond $3.01 / -2.84 (-48.55%) 02/07/23 Hudson Bay anchor investor of Bed Bath share sale, Bloomberg reports 02/02/23 Bed Bath & Beyond misses interest payments, weighs Chapter 11, WSJ reports 01/31/23 Bed Bath & Beyond prepares to seek bankruptcy protection, Reuters reports 01/29/23 Bed Bath & Beyond to close 87 more stores, Harmon chain, WSJ reports TGT BBBY TGT Target $174.77 / +0.885 (+0.51%) 01/28/23 Buy/Sell: Wall Street's top 10 stock calls this week 01/24/23 What You Missed On Wall Street On Tuesday 01/24/23 What You Missed On Wall Street This Morning 01/24/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations BBBY Bed Bath & Beyond $3.01 / -2.84 (-48.55%) 02/07/23 What You Missed On Wall Street On Tuesday 02/07/23 What You Missed On Wall Street This Morning 02/07/23 Fly Intel: Pre-market Movers 02/06/23 Fly Intel: After-Hours Movers TGT BBBY TGT Target $174.77 / +0.885 (+0.51%) 01/19/23 Target put volume heavy and directionally bearish 01/06/23 Early notable gainers among liquid option names on January 6th 01/06/23 Unusually active option classes on open January 6th 11/28/22 Early notable gainers among liquid option names on November 28th BBBY Bed Bath & Beyond $3.01 / -2.84 (-48.55%) 02/07/23 Notable open interest changes for February 7th 02/07/23 Bed Bath & Beyond call buyer realizes 918% same-day gains 02/01/23 Notable open interest changes for February 1st 01/27/23 Notable open interest changes for January 27th
Earnings	Edgewell Personal Care reports Q1 adjusted EPS 31c, consensus 21c » 06:08 02/08/23 02/08 06:08 02/08/23 06:08 EPC Edgewell Personal Care $42.14 / -0.85 (-1.98%) Reports Q1 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events EPC Edgewell Personal Care $42.14 / -0.85 (-1.98%) 12/16/22 Edgewell Personal Care names Robert Schmidt as Chief Accounting Officer 09/15/22 Edgewell Personal Care streamlines leadership and organizational structure EPC Edgewell Personal Care $42.14 / -0.85 (-1.98%) 11/16/22 Canaccord Canaccord starts Edgewell Personal Care at Buy amid men's 'beauty boom' 11/16/22 Canaccord Edgewell Personal Care initiated with a Buy at Canaccord 11/14/22 Barclays Edgewell Personal Care price target raised to $35 from $31 at Barclays 10/25/22 Goldman Sachs Edgewell downgraded to Neutral from Conviction Buy at Goldman Sachs EPC Edgewell Personal Care $42.14 / -0.85 (-1.98%) 11/10/22 Edgewell Personal Care sees FY23 adjusted EPS $2.30-$2.50, consensus $2.56 11/10/22 Edgewell Personal Care reports Q4 adjusted EPS 79c, consensus 76c 08:00 Today Edgewell Personal Care - EPC
Earnings	Ingredion sees FY23 adjusted EPS $7.70-$8.40, consensus $8.22 » 06:08 02/08/23 02/08 06:08 02/08/23 06:08 INGR Ingredion $100.65 / -0.835 (-0.82%) The company expects… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events INGR Ingredion $100.65 / -0.835 (-0.82%) 12/01/22 Ingredion gets SBTi approval of its greenhouse gas emissions reduction targets 11/07/22 Ingredion completes one-third of its $160M in capital investments 09/26/22 Ingredion announces 6M share repurchase plan 09/26/22 Ingredion increases quarterly dividend 9% to 71c per share INGR Ingredion $100.65 / -0.835 (-0.82%) 01/23/23 Barclays Ingredion downgraded to Equal Weight from Overweight at Barclays 01/17/23 Stephens Ingredion upgraded to Overweight from Equal Weight at Stephens 11/07/22 Credit Suisse Ingredion price target raised to $100 from $94 at Credit Suisse 09/30/22 UBS Ingredion initiated with a Neutral at UBS INGR Ingredion $100.65 / -0.835 (-0.82%) 06:06 Today Ingredion reports Q4 adjusted EPS $1.65, consensus $1.45 11/03/22 Ingredion narrows FY22 adjusted EPS view to $7.00-$7.45 from $6.90-$7.45 11/03/22 Ingredion reports Q3 adjusted EPS $1.73, consensus $1.62 08/09/22 Ingredion sees FY22 adjusted EPS $6.90-$7.45, consensus $7.14 INGR Ingredion $100.65 / -0.835 (-0.82%) 01/23/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 09/26/22 Fly Intel: After-Hours Movers 09:00 Today Ingredion - INGR

Upgrade	Royal Caribbean upgraded to Neutral from Underperform at BofA » 06:07 02/08/23 02/08 06:07 02/08/23 06:07 RCL Royal Caribbean $74.05 / +4.96 (+7.18%) BofA analyst Andrew… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options RCL Royal Caribbean $74.05 / +4.96 (+7.18%) 02/07/23 Royal Caribbean jumps 5% to $72.54 after reporting Q4 results, FY23 guidance 02/07/23 Royal Caribbean sees FY23 CapEx $4.1B 02/07/23 Royal Caribbean 'very encouraged about the demand environment for 2023' 01/12/23 Royal Caribbean amends, extends revolving credit facilities RCL Royal Caribbean $74.05 / +4.96 (+7.18%) 05:34 Today Barclays Royal Caribbean price target raised to $88 from $74 at Barclays 04:44 Today Deutsche Bank Royal Caribbean price target raised to $65 from $62 at Deutsche Bank 01/31/23 Citi Royal Caribbean offers most value in cruise sector, says Citi 01/20/23 Deutsche Bank Royal Caribbean price target raised to $62 from $48 at Deutsche Bank RCL Royal Caribbean $74.05 / +4.96 (+7.18%) 02/07/23 Royal Caribbean sees FY23 adjusted EPS $3.00-$3.60, consensus $3.25 02/07/23 Royal Caribbean sees Q1 adjusted EPS (85c)-(65c), consensus (80c) 02/07/23 Royal Caribbean reports Q4 adjusted EPS ($1.12), consensus ($1.34) 11/03/22 Royal Caribbean sees Q4 adjusted EPS ($1.50)-($1.30), consensus (67c) RCL Royal Caribbean $74.05 / +4.96 (+7.18%) 08/17/22 Royal Caribbean seeks approval to sail again in Hong Kong, SCMP reports 08/13/22 Royal Caribbean among companies at risk of liquidity squeeze, Barron's says RCL Royal Caribbean $74.05 / +4.96 (+7.18%) 02/07/23 What You Missed On Wall Street On Tuesday 02/07/23 What You Missed On Wall Street This Morning 01/10/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/10/22 Buy/Sell: Wall Street's top 10 stock calls this week 03/03/23 South Florida Cruise Tour 2023 03/08/23 Bus Tour RCL Royal Caribbean $74.05 / +4.96 (+7.18%) 02/07/23 Early notable gainers among liquid option names on February 7th 02/07/23 Unusually active option classes on open February 7th 01/19/23 Royal Caribbean put volume heavy and directionally bearish 12/21/22 Early notable gainers among liquid option names on December 21st
Earnings	Ingredion reports Q4 adjusted EPS $1.65, consensus $1.45 » 06:06 02/08/23 02/08 06:06 02/08/23 06:06 INGR Ingredion $100.65 / -0.835 (-0.82%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events INGR Ingredion $100.65 / -0.835 (-0.82%) 12/01/22 Ingredion gets SBTi approval of its greenhouse gas emissions reduction targets 11/07/22 Ingredion completes one-third of its $160M in capital investments 09/26/22 Ingredion announces 6M share repurchase plan 09/26/22 Ingredion increases quarterly dividend 9% to 71c per share INGR Ingredion $100.65 / -0.835 (-0.82%) 01/23/23 Barclays Ingredion downgraded to Equal Weight from Overweight at Barclays 01/17/23 Stephens Ingredion upgraded to Overweight from Equal Weight at Stephens 11/07/22 Credit Suisse Ingredion price target raised to $100 from $94 at Credit Suisse 09/30/22 UBS Ingredion initiated with a Neutral at UBS INGR Ingredion $100.65 / -0.835 (-0.82%) 11/03/22 Ingredion narrows FY22 adjusted EPS view to $7.00-$7.45 from $6.90-$7.45 11/03/22 Ingredion reports Q3 adjusted EPS $1.73, consensus $1.62 08/09/22 Ingredion sees FY22 adjusted EPS $6.90-$7.45, consensus $7.14 08/09/22 Ingredion reports Q2 adjusted EPS $2.12, consensus $1.94 INGR Ingredion $100.65 / -0.835 (-0.82%) 01/23/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 09/26/22 Fly Intel: After-Hours Movers 09:00 Today Ingredion - INGR
Hot Stocks	Maxar Technologies awarded $192M contract by the NGA » 06:06 02/08/23 02/08 06:06 02/08/23 06:06 MAXR Maxar Technologies $51.67 / +0.03 (+0.06%) Maxar Technologies… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options MAXR Maxar Technologies $51.67 / +0.03 (+0.06%) 01/04/23 Maxar Technologies announces new contract awards from NGA worth up to $35.8M 12/16/22 Maxar Technologies rises 122.5% 12/16/22 Maxar Technologies rises 119.6% 12/16/22 Maxar Technologies rises 120.5% MAXR Maxar Technologies $51.67 / +0.03 (+0.06%) 12/27/22 Morgan Stanley Morgan Stanley says space-related M&A highlight attractiveness of end market 12/19/22 Northland Maxar deal sheds light on growing value of Planet Labs data, says Northland 12/19/22 TD Securities Maxar Technologies downgraded to Tender from Buy at TD Securities 12/19/22 RBC Capital Maxar Technologies downgraded to Sector Perform from Outperform at RBC Capital MAXR Maxar Technologies $51.67 / +0.03 (+0.06%) 11/03/22 Maxar Technologies reports Q3 EPS (5c), consensus 29c 08/09/22 Maxar Technologies reports Q2 EPS (41c) vs 62c last year MAXR Maxar Technologies $51.67 / +0.03 (+0.06%) 12/19/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/16/22 What You Missed On Wall Street On Friday 12/16/22 Sell these stocks now, proven algorithm says 12/16/22 What You Missed On Wall Street This Morning MAXR Maxar Technologies $51.67 / +0.03 (+0.06%) 12/20/22 Maxar Technologies put volume heavy and directionally bearish
Earnings	CVS Health sees FY24 adjusted EPS $9.00, FY25 adjusted EPS $10.00 » 06:05 02/08/23 02/08 06:05 02/08/23 06:05 CVS CVS Health $86.02 / +0.77 (+0.90%) The company said,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CVS CVS Health $86.02 / +0.77 (+0.90%) 06:03 Today CVS Health to acquire Oak Street Health for $39 per share 01/26/23 Medavail to sell certain SpotRx pharmacy assets to CVS Health 01/23/23 CVS Health names Bricker CPO, Joyner rejoins as pharmacy services president 01/17/23 Oak Street Health down 7% in afternoon trading CVS CVS Health $86.02 / +0.77 (+0.90%) 02/07/23 Stifel Oak Street Health price target raised to $39 from $35 at Stifel 02/07/23 Piper Sandler Oak Street 'particularly attractive' in current environment, says Piper Sandler 01/31/23 JPMorgan Medicare Advantage final rule more favorable than feared, says JPMorgan 01/27/23 Lake Street Medavail price target lowered to $1 from $4 at Lake Street CVS CVS Health $86.02 / +0.77 (+0.90%) 06:04 Today CVS Health backs FY23 adjusted EPS view $8.70-$8.90, consensus $8.86 02/07/23 Notable companies reporting before tomorrow's open 02/07/23 Notable companies reporting before tomorrow's open 01/10/23 CVS Health reaffirms FY23 adjusted EPS view $8.70-$8.90, consensus $8.86 CVS CVS Health $86.02 / +0.77 (+0.90%) 02/06/23 CVS Health near deal to acquire Oak Street Health for $10.5B, WSJ says 02/06/23 CVS Health near deal to acquire Oak Street Health for $10.5B, WSJ says 01/27/23 Cigna sues CVS Health, Amy Bricker for violating noncompete, Bloomberg Law says 01/19/23 Rite Aid plans to provide abortion pill in some stores, Bloomberg reports CVS CVS Health $86.02 / +0.77 (+0.90%) 02/07/23 What You Missed On Wall Street On Tuesday 02/07/23 What You Missed On Wall Street This Morning 02/07/23 Fly Intel: Pre-market Movers 01/27/23 What You Missed On Wall Street This Morning 02/24/23 Annual Meeting of AAAAI 2023 08:00 Today CVS Health - CVS CVS CVS Health $86.02 / +0.77 (+0.90%) 11/28/22 CVS Health put volume heavy and directionally bearish 11/02/22 Unusually active option classes on open November 2nd 10/19/22 Unusually active option classes on open October 19th 09/13/22 CVS Health call volume above normal and directionally bullish
Earnings	Bunge sees FY23 adjusted EPS 'at least' $11.00, consensus $12.00 » 06:05 02/08/23 02/08 06:05 02/08/23 06:05 BG Bunge $98.92 / -0.64 (-0.64%) In Agribusiness,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events BG Bunge $98.92 / -0.64 (-0.64%) 02/07/23 Bunge increases monitoring of soybeans from indirect supply chain in Brazil 11/22/22 Bunge to acquire 49% stake in BZ Group, terms undisclosed 10/13/22 Bunge, Olleco announce 50/50 edible oils joint venture 10/10/22 Bunge announces over 100 new trainee, internship positions in North America BG Bunge $98.92 / -0.64 (-0.64%) 12/14/22 UBS UBS starts Bunge at Buy on near-term earnings power 12/13/22 UBS Bunge initiated with a Buy at UBS 10/24/22 BofA Green Plains price target lowered to $35 from $43 at BofA 10/24/22 BofA Bunge price target lowered to $130 from $138 at BofA BG Bunge $98.92 / -0.64 (-0.64%) 06:01 Today Bunge reports Q4 adjusted EPS $3.24, consensus $3.22 10/26/22 Bunge raises FY22 adjusted EPS view to at least $13.50 from at least $12.00 10/26/22 Bunge reports Q3 adjusted EPS $3.45, consensus $2.43 BG Bunge $98.92 / -0.64 (-0.64%) 11/30/22 EPA to propose boost in biofuel quotas, Reuters reports 11/30/22 President Biden plans to boost biofuel quotas for next 3 years, Bloomberg says BG Bunge $98.92 / -0.64 (-0.64%) 12/14/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08:00 Today Bunge - BG

Events

Earnings calls, analyst events, roadshows and more

Today at 07:00

MBA Mortgage Applications: Refinance Index W/W: 2/3/2023 Government Event
Today at 07:00

MBA Mortgage Applications: Composite Index W/W: 2/3/2023 Government Event
Today at 07:00

MBA Mortgage Applications: Purchase Index W/W: 2/3/2023 Government Event
EQNR
Today at 07:00

Equinor - EQNR Conference Calls
ITUB
Today at 08:00

Itau Unibanco - ITUB Conference Calls
TRMB
Today at 08:00

Trimble - TRMB Conference Calls
AIZ
Today at 08:00

Assurant - AIZ Conference Calls
CRTO
Today at 08:00

Criteo - CRTO Conference Calls
TEVA
Today at 08:00

Teva - TEVA Conference Calls
CVS
Today at 08:00

CVS Health - CVS Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	BLNK X BLNK Blink Charging Spot Secondary Managers: Barclays Priced at: $12.00 8.333M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	LBPH X LBPH Longboard Pharmaceuticals Spot Secondary Managers: Evercore ISI & Cantor Fitzgerald Priced at: $4.00 5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SINT X SINT Sintx Technologies Spot Secondary Managers: Maxim Priced at: $5.60 2.15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial STAF X STAF Staffing 360 Solutions Spot Secondary Managers: H.C. Wainwright Priced at: $2.65 1.88M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TMCI X TMCI Treace Medical Spot Secondary Managers: BTIG Priced at: $21.00 4.76M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	CVAC X CVAC CureVac Secondary Managers: Goldman Sachs, Jefferies, SVB Securities & Kempen $10.58 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DT X DT Dynatrace Spot Secondary Managers: BofA $45.55-47.00 15M Shares FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan, Goldman Sachs & Morgan Stanley $139.40-142.25 2M Shares RXST X RXST RxSight Spot Secondary Managers: BofA $12.50-13.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial XPOF X XPOF Xponential Fitness Spot Secondary Managers: BofA & Jefferies $24.00-25.00 5M Shares
Wed	BFRG X BFRG Bullfrog AI IPO Managers: WallachBeth, Kingswood $6.50 1.32M Shares HSAI X HSAI Hesai IPO Managers: Goldman Sachs, Morgan Stanley & Credit Suisse, Huatai Securities $17.00 - 19.00 9M Shares INTS X INTS Intensity Therapeutics IPO Managers: Benchmark $4.00-4.50 1.778M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NXT X NXT Nextracker IPO Managers: JPMorgan, BofA, Citi & Barclays, Truist, HSBC, BNP Paribas, Mizuho, Scotiabank, KeyBanc $20.00-23.00 23.26M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	ENLT X ENLT Enlight Renewable Energy IPO Managers: JPMorgan, BofA & Barclays, Credit Suisse, Wolfe Research, Nomura, HSBC, Roth MKM $20.57 14M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LEWY X LEWY LeeWay Services IPO Managers: ThinkEquity $5.00 1M Shares MLYS X MLYS Mineralys Therapeutics IPO Managers: BofA, Ever Bank, Stifel, Credit Suisse, Guggenheim & Wells Fargo $14.00-16.00 10M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Crypto lender BlockFi files for bankruptcy amid FTX 'entanglement,' NYT says

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access